Moderna Inc (NASDAQ:MRNA)
| 67.87 Delayed Data As of Aug 13 |  -1.69 / -2.43%Today’s Change | 12.47 Today|||52-Week Range 95.21 | +246.98% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 69.52 |
| Today’s open | 69.09 |
| Day’s range | 67.05 - 69.18 |
| Volume | 15,055,934 |
| Average volume (3 months) | 23,720,508 |
| Market cap | $29.2B |
Data as of 7:18pm ET, 08/13/2020
Growth & Valuation
| Earnings growth (last year) | +68.63% |
| Earnings growth (this year) | +13.20% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | -55.42% |
| P/E ratio | NM |
| Price/Sales | 107.47 |
| Price/Book | 21.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | -1.15 | -0.97% |
| EXASExact Sciences Corp | +0.05 | +0.06% |
| NBIXNeurocrine Bioscienc... | +0.54 | +0.47% |
| TECHBio-Techne Corp | +2.87 | +1.09% |
Data as of 4:00pm ET, 08/13/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $60.2M |
| Annual profit (last year) | -$514.0M |
| Net profit margin | -853.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
